Vanguard Group’s Skye Bioscience SKYE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.5M | Sell |
837,961
-115,411
| -12% | -$482K | ﹤0.01% | 3326 |
|
|
2025
Q1 | $1.52M | Buy |
953,372
+92,545
| +11% | +$147K | ﹤0.01% | 3579 |
|
|
2024
Q4 | $2.44M | Buy |
860,827
+16,654
| +2% | +$47.1K | ﹤0.01% | 3500 |
|
|
2024
Q3 | $3.3M | Buy |
844,173
+10,553
| +1% | +$41.3K | ﹤0.01% | 3412 |
|
|
2024
Q2 | $6.68M | Buy |
+833,620
| New | +$6.68M | ﹤0.01% | 3119 |
|